(Q43831854)

27 November 2017

Critical appraisal of the mouse model of myocardial infarction (English)

1 reference

27 November 2017

myocardial infarction

1 reference

Naomi M Degabriele

1

1 reference

27 November 2017

Uta Griesenbach

2

1 reference

27 November 2017

Kaori Sato

3

1 reference

27 November 2017

Mark J Post

4

1 reference

27 November 2017

Jie Zhu

5

1 reference

27 November 2017

John Williams

6

1 reference

27 November 2017

Peter K Jeffery

7

1 reference

27 November 2017

Duncan M Geddes

8

1 reference

27 November 2017

Eric W F W Alton

9

1 reference

27 November 2017

6 May 2004

1 reference

27 November 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Experimental Physiology

1 reference

27 November 2017

89

1 reference

27 November 2017

4

1 reference

27 November 2017

497-505

1 reference

Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice.

27 November 2017

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.027276

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.027276

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.027276

Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.027276

Myocardial infarct size and ventricular function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.027276

Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.027276

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.027276

Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.027276

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.027276

Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2004.027276

10.1113/EXPPHYSIOL.2004.027276

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference